The Financial Market Authority (FMA) Liechtenstein has imposed a temporary prohibition, effective as of 16 August 2010, on Quantum Leben AG to conclude new insurance contracts. This means that no new insurance contracts may be taken out with Quantum Leben AG until further notice.
The Liechtenstein supervisor states that it took the measure in order to protect the interests of persons who have already taken out insurance with Quantum Leben AG. The measure is necessary because there are, according to the FMA, uncertainties about whether Quantum Leben AG satisfies the capital requirements.
Quantum Leben AG is a Liechtenstein life insurer that offers products on the Dutch market that provide coverage in the event of death and occupational disability. Quantum Leben AG does not fall under the DNB's prudential supervision, but under the supervision of the FMA, the Liechtenstein supervisor.
TAF B.V. represents Quantum Leben AG in the Netherlands. TAF B.V. has an AFM licence and sells Quantum Leben AG insurance products via brokers. These brokers and TAF B.V. fall under AFM market conduct supervision and are not allowed to sell Quantum Leben AG insurance products. Agreements between current policyholders and Quantum Leben AG will remain in effect in full.
DNB and the AFM are in continuous contact with the FMA in the interest of the Dutch policyholders.
The AFM is committed to promoting fair and transparent financial markets.
As an independent market conduct authority, we contribute to a sustainable financial system and prosperity in the Netherlands.